GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AREV Life Sciences Global Corp (OTCPK:AREVF) » Definitions » ROIC %

AREVF (AREV Life Sciences Global) ROIC % : -38.10% (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is AREV Life Sciences Global ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. AREV Life Sciences Global's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2023 was -38.10%.

As of today (2024-09-25), AREV Life Sciences Global's WACC % is 18.21%. AREV Life Sciences Global's ROIC % is -80.05% (calculated using TTM income statement data). AREV Life Sciences Global earns returns that do not match up to its cost of capital. It will destroy value as it grows.


AREV Life Sciences Global ROIC % Historical Data

The historical data trend for AREV Life Sciences Global's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AREV Life Sciences Global ROIC % Chart

AREV Life Sciences Global Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -290.41 -338.94 -53.74 -227.82 -466.82

AREV Life Sciences Global Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -290.11 165.67 -295.12 -180.90 -38.10

Competitive Comparison of AREV Life Sciences Global's ROIC %

For the Drug Manufacturers - Specialty & Generic subindustry, AREV Life Sciences Global's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AREV Life Sciences Global's ROIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AREV Life Sciences Global's ROIC % distribution charts can be found below:

* The bar in red indicates where AREV Life Sciences Global's ROIC % falls into.



AREV Life Sciences Global ROIC % Calculation

AREV Life Sciences Global's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2022 is calculated as:

ROIC % (A: Dec. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2021 ) + Invested Capital (A: Dec. 2022 ))/ count )
=-1.027 * ( 1 - 0% )/( (0.282 + 0.158)/ 2 )
=-1.027/0.22
=-466.82 %

where

AREV Life Sciences Global's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2023 is calculated as:

ROIC % (Q: Sep. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Sep. 2023 ))/ count )
=-0.084 * ( 1 - 0% )/( (0.228 + 0.213)/ 2 )
=-0.084/0.2205
=-38.10 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AREV Life Sciences Global  (OTCPK:AREVF) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, AREV Life Sciences Global's WACC % is 18.21%. AREV Life Sciences Global's ROIC % is -80.05% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


AREV Life Sciences Global ROIC % Related Terms

Thank you for viewing the detailed overview of AREV Life Sciences Global's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


AREV Life Sciences Global Business Description

Traded in Other Exchanges
N/A
Address
91 Golden Drive, Unit 18, Coquitlam, BC, CAN, V3K 6R2
AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.